Mayne Pharma Group Limited MAYNF
1.85 USD -0.02 -1.07%
At close · Oct 30
- YTD
- -10.63%
- 1 year
- -53.75%
- Open
- 1.85
- Prev close
- 1.87
- Mkt cap
- 151.50M
- Vol
- 3.10K
- Avg vol
- 1.26K
- EPS
- 0.21
- P/E
- 8.81
More statistics
- Low
- 1.85
- High
- 1.85
MAX chart
Chart tools
Chart is warming up
The all-time price history for MAYNF has not been loaded yet. Try again in a moment.
Altman Z-Score
-0.99 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B+3 / 5 overall
- DCF 1
- Return on Equity 3
- Return on Assets 3
- Debt / Equity 3
- P/E 4
- P/B 5
P/E 7.9×
P/S 0.5×
P/B 0.5×
P/FCF 15.1×
EV/EBITDA 5.2×
EV/Sales 0.4×
FCF Yield 6.6%
Gross Margin 50.1%
Operating Margin -8.9%
Net Margin 6.4%
ROE 6.3%
ROIC -4.3%
ROA 2.7%
Revenue -6.1%
Operating Income -45.1%
EPS (diluted) 117.5%
Free Cash Flow 143.7%
Current Ratio 1.3×
Quick Ratio 1.1×
Debt / Equity 0.1×
Net Debt / EBITDA -1.3×
Interest Coverage -6.5×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2026-06-30